Zami Aberman
Chairman & Co-CEO,
Pluristem Therapeutics
Usman Azam
Chief Executive Officer,
Tmunity Therapeutics
Ron Bartek
Co-Founder and President,
Friedreich's Ataxia Research Alliance
Amy Butler
VP and GM Cell Biology,
Thermo Fisher Scientific
Deborah Dean
Executive Vice President & Chief Compliance Officer,
MiMedx
Flagg Flanagan
Chairman and CEO,
DiscGenics
Michael Hunt
Chief Financial Officer,
ReNeuron
Dena Ladd
Executive Director,
Missouri Cures
Paul Laikind
President & CEO,
ViaCyte
Bruce Levine
Founding Director, Clinical Cell and Vaccine Production Facility,
Abramson Cancer Center, University of Pennsylvania
Michael May
President & Chief Executive Officer,
Centre for Commercialization of Regenerative Medicine (CCRM)
Emile Nuwaysir
President & Chief Executive Officer,
BlueRock Therapeutics
Isabelle Riviere
Director, Cell Therapy and Cell Engineering Facility,
Memorial Sloan Kettering Cancer Center
Sanjaya Singh
Vice President and Global Head,
Janssen Pharmaceutical Companies of Johnson & Johnson, Janssen Research & Development
Donna Skerrett
Chief Medical Officer,
Mesoblast Limited
Bob Smith
SVP, Global Gene Therapy Business,
Pfizer
Joe Tarnowski
SVP, Cell and Gene Therapy Platform,
GlaxoSmithKline
Keith Thompson
Chief Executive Officer,
Cell & Gene Therapy Catapult
Gil Van Bokkelen
President & CEO,
Athersys
Phil Vanek
General Manager, Cell Therapy Growth Strategies,
GE Healthcare LIfe Sciences
Jeffrey Walsh
Chief Financial and Strategy Officer,
bluebird bio
Susan Washer
President & CEO,
AGTC
Jason Wertheim
Assistant Professor of Surgery - Organ Transplantation, Department of Surgery, Institute for BioNanotechnology in Medicine, Feinberg School of Medicine and Chemistry of Life Processes Institute,
Northwestern University
Claudia Zylberberg
Founder & CEO,
Akron Biotech
